Skip to content

Laxmikant S Deshpande

Departments of Neurology (A.R.-D., E.H., L.S.D.), Pharmacology and Toxicology (L.S.D.), School of Medicine, Virginia Commonwealth University, Richmond, Virginia and Department of Pharmacotherapy and Outcome Sciences (D.Y.A.S., F.M.J., J.L.M.), School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia laxmikant.deshpande@vcuhealth.org.

1 paper in the library · 10 citations · publishing 2024

Papers

Ketamine Produces Antidepressant Effects by Inhibiting Histone Deacetylases and Upregulating Hippocampal Brain-Derived Neurotrophic Factor Levels in a Diisopropyl Fluorophosphate-Based Rat Model of Gulf War Illness.

The Journal of pharmacology and experimental therapeutics January 17, 2024 Ana Ribeiro-Davis, Dalia Y Al Saeedy, Fay M Jahr et al. 10 citations

In a rat model of Gulf War Illness (GWI), a single antidepressant dose of ketamine reversed epigenetic changes in the hippocampus. Ketamine inhibited the upregulation of histone deacetylase enzymes, restored acetylation at the Bdnf gene promoter, and increased brain-derived neurotrophic factor (BDNF) protein expression. It also increased dendritic spine density and altered spine types, shifting from S-type to T-type spines. These results suggest ketamine's antidepressant effect in GWI-related depression involves histone modifications that boost BDNF and reshape synaptic connections, supporting further clinical trials for GWI-related depression.